Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development

Cancer Research

Volumn 65, Issue 20, 2005, Pages 9304-9311

  Sung, You Me ^a   He, Guobin ^a   Fischer, Susan M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLIC AMP; INTERLEUKIN 1ALPHA; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; CELL PROLIFERATION; COLON CARCINOGENESIS; CONTROLLED STUDY; EPIDERMIS; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CARCINOGENS; CELL GROWTH PROCESSES; CELL TRANSFORMATION, NEOPLASTIC; CYCLIC AMP; DINOPROSTONE; DRUG ERUPTIONS; FEMALE; HYPERPLASIA; KERATINOCYTES; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, PROSTAGLANDIN E; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE;

EID: 27144540917     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1015     Document Type: Article

References (45)

1. Cao Y, Prescott SM. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002;190:279-86.
2. Maldve RE, Kim Y, Muga SJ, Fischer SM. Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lipid Res 2000;41:873-81.
3. Fischer SM, Lo HH, Gordon GB, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999;25:231-40.
4. Maldve RE, Fischer SM. Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol Carcinog 1996;17:207-16.
5. Conconi MT, Bruno P, Bonali AR, et al. Relationship between the proliferation of keratinocytes cultured in vitro and prostaglandin E2. Ann Anat 1996;178:229-36.
6. Rys-Sikora KE, Konger RL, Schoggins JW, et al. Coordinate expression of secretory phospholipase A(2) and cyclooxygenase-2 in activated human keratinocytes. Am J Physiol Cell Physiol 2000;278:822-33.
7. Goldyne ME, Evans CB. 12-0-tetradecanoylphorbol-13-acetate and the induction of prostaglandin E2 generation by human keratinocytes: a re-evaluation. Carcinogenesis 1994;15:141-3.
8. Regan JW. EP2 and EP4 prostanoid receptor signaling. Life Sci 2003;74:143-53.
9. Konger RL, Malaviya R, Pentland AP. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes. Biochim Biophys Acta 1998;1401:221-34.
10. Sonoshita M, Takaku K, Sasaki N, et al. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Ape (Delta 716) knockout mice. Nat Med 2001;7:1048-51.
11. Eibl G, Bruemmer D, Okada Y, et al. PGE(2) is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells. Biochem Biophys Res Commun 2003;306:887-97.
12. Chang SH, Liu CH, Conway R, et al. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A 2004;101:591-6.
13. Fujino H, West KA, Regan JW. Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J Biol Chem 2002;277:2614-9.
14. Sales KJ, Maudsley S, Jabbour HN. Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. Mol Endocrinol 2004;18:1533-45.
15. Murphy JE, Morales RE, Scott J, et al. IL-1α, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1α in epidermis on chemical carcinogenesis. J Immunol 2003;170:5697-703.
16. Takafuji V, Cosme R, Lublin D, et al. Prostanoid receptors in intestinal epithelium: selective expression, function, and change with inflammation. Prostaglandins Leukot Essent Fatty Acids 2000;63:223-35.
17. Mize NK, Buttery M, Daddona P, et al. Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo, Exp Dermatol 1997;6:298-302.
18. Fischer SM, Lo HH, Gordon GB, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999;25:231-40.
19. Pentland AP, Schoggins JW, Scott GA, et al. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 1999;20:1939-44.
20. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992;54:63-128.
21. Tilley SL, Audoly LP, Hicks EH, et al. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest 1999;103:1539.
22. Fleming EF, Athirakul K, Oliverio MI, et al. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am J Physiol 1998;275:F955.
23. Yuspa SH. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis: thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res 1994;54:1178-89.
24. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999;68:821-61.
25. Hoper MM, Voelkel NF, Bates TO, et al. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol 1997;17:748-56.
26. Lee RJ, Albanese C, Stenger RJ, et al. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways. A role for cAMP response element-binding protein and activating transcription foctor-2 in pp60(v-src) signaling in breast cancer cells. J Biol Chem 1999;274:7341-50.
27. Desdouets C, Matesic G, Molina CA, et al. Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM. Mol Cell Biol 1995;15:3301-9.
28. Majima M, Isono M, Ikeda Y, et al. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn J Pharmacol 1997;75:105-14.
29. Ghosh AK, Hirasawa N, Niki H, et al. Cyclooxygenase-2-mediated angiogenesis in carrageenin-induced granulation tissue in rats. J Pharmacol Exp Ther 2000;295:802-9.
30. Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis [review]. Int J Mol Med 1998;2:715-9.
31. Sawaoka H, Tsuji S, Tsujii M, et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 1999;79:1469-77.
32. Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-6.
33. Lu X, Xie W, Reed D, et al. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci U S A 1995;92:7961-5.
34. Nishihara H, Kizaka-Kondoh S, Insel PA, et al. Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc Natl Acad Sci U S A 2003;100:8921-6.
35. Ueda T, Akiyama N, Sai H, et al. C-IAP2 is induced by ionizing radiation through NF-κB binding sites. FEBS Lett 2001;491:40-4.
36. Fischer SM, Patrick KE, Patamalai B, et al. Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes. Carcinogenesis 1990;11:991-6.
37. Murakami A, Nakamura Y, Torikai K, et al. Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 2000;60:5059-66.
38. Wilgus TA, Parrett ML, Ross MS, et al. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Adv Exp Med Biol 2002;507:85-92.
39. Fischer SM, Cameron GS, Baldwin JK, et al. Reactive oxygen in the tumor promotion stage of skin carcinogenesis. Lipids 1988;23:592-7.
40. De Visser KE, Korets LV, Coussens LM. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005;7:411-23.
41. Watanabe K, Kawamori T, Nakatsugi S, et al. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res 1999;59:5093-6.
42. Mutoh M, Watanabe K, Kitamura T, et al. Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res 2002;62:28-32.
43. Kitamura T, Itoh M, Noda T, et al. Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Sci 2003;94:618-21.
44. Kawamori T, Kitamura T, Watanabe K, et al. Prostaglandin E receptor subtype EP1 deficiency inhibits colon cancer development. Carcinogenesis 2005;26:353-7.
45. Thompson EJ, Gupta A, Vielhauer GA, et al. The growth of malignant keratinocytes depends on signaling through the PGE2 receptor EP1. Neoplasia 2001;3:402-10.